Work

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198

Year: 2010

Type: article

Study design: Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-010-0838-7

Authors: Antonio C. Wolff, Molin Wang, Hailun Li, Michael R. Pins, Florence J. Pretorius, Kendrith M. Rowland, Joseph A. Sparano, Nancy E. Davidson

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Dana-Farber Cancer Institute, Northwestern University, Advocate Lutheran General Hospital, University of Pretoria, Carle Foundation Hospital, Albert Einstein College of Medicine, Yeshiva University, Montefiore Einstein Comprehensive Cancer Center, UPMC Hillman Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, Mayo Clinic, Johns Hopkins University, National Institutes of Health, Genentech, National Cancer Institute

Awards: ECOG Statistical Office Data Management Grant, G1422427855, G1771393403, G2679961467, G286468852, G3762168461, G3996959562, G4412485521, G5765316850, G608154585, G6944741171, EASTERN COOPERATIVE ONCOLOGY GROUP, Eastern Cooperative Oncology Group Operations Office, G851727279, G92717670, G964706321

OpenAlex ID: W2055901268

FWCI: 1.992

Cites: 39

Cited by: 29

Related to: 10